Skip to main content
logo
Apellis Pharmaceuticals, Inc. (APLS)
May 14, 2026 - APLS was delisted (reason: acquired by BIIB)
41.03
-0.03 (-0.07%)
Inactive · Last trade price on May 13, 2026

Apellis Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
133.2722.39-197.88-528.63-652.17-746.35
Depreciation & Amortization
1.41.561.81.781.551.49
Stock-Based Compensation
-2.2-114.13105.9591.0970.67
Other Adjustments
1.912.512.4426.4161.55204.59
Change in Receivables
-205.03-101.28-58.48-198.722.38-10.1
Changes in Inventories
-10.46-15.27-10.76-60.65-69.4-16.32
Changes in Accounts Payable
-6.2318.221.090.1718.6910.49
Changes in Accrued Expenses
24.3825.3918.1534.95-6.31-10.39
Changes in Other Operating Activities
-17.93-12.1831.6423.9938.88-67.2
Operating Cash Flow
37.7745.33-87.87-594.74-513.75-563.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.31-0.31-0.4-0.77-1.52-1.1
Sale of Property, Plant & Equipment
---0.1--
Purchases of Investments
-----331.86-171.28
Proceeds from Sale of Investments
----393.28420
Investing Cash Flow
-0.31-0.31-0.4-0.6759.89247.62

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--365.45---
Net Short-Term Debt Issued (Repaid)
--365.45---
Issuance of Common Stock
7.68.918.83461.04405.84398.02
Repurchase of Common Stock
-0.03-0.01-0.06-11.04-5.68-1.79
Net Common Stock Issued (Repurchased)
7.588.8818.77450400.16396.24
Other Financing Activities
---234.98-55.5-34.5-4
Financing Cash Flow
8.678.88149.24394.5365.66392.24

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.761.25-0.660.14-0.49-2.02
Net Cash Flow
46.955.1560.31-200.78-88.6874.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
37.4745.01-88.27-595.51-515.27-564.23
Free Cash Flow Growth
------
FCF Margin
3.39%4.48%-11.30%-150.16%-683.18%-847.66%
Free Cash Flow Per Share
0.290.35-0.71-5.02-4.86-6.68
Levered Free Cash Flow
261.4639.79209.1-529.15-670.28-829.38
Unlevered Free Cash Flow
153.7868.87-124.43-519.74-613.33-619.56
SEC Filings: 10-K · 10-Q